How A New Biopharma CEO Approaches Diversity & Inclusion
Source: Life Science Leader
Michael McCullar, Ph.D., who joined OnQuality Pharmaceuticals as the company’s CEO in Dec. 2020, shares thoughts on his approach to diversity and inclusion (D&I) as a newly appointed leader. The full executive virtual roundtable, “Making Diversity & Inclusion A Best Business Practice,” can be viewed here.
This website uses cookies to ensure you get the best experience on our website. Learn more